Categories: Appointment

New Managing Director for LANXESS in India

Neelanjan Banerjee succeeds Jacques Perez

Thane, July 24, 2018: Neelanjan Banerjee, age 45 years, will be the new Country Representative and Managing Director for India effective September 1, 2018. He will assume these tasks in addition to his current function as head of the Advanced Industrial Intermediates business unit (BU AII) in India. Banerjee joined LANXESS in 2006 as head of the former Basic Chemicals business unit and the Saltigo business unit in India.

Banerjee follows Jacques Perez, age 56 years, who  will take over new responsibilities as Managing Director of LANXESS Holding UK Unlimited and Country Representative of LANXESS in the United Kingdom. Born in France, he has also held the position of Chief Financial Officer (CFO) of LANXESS India Private Limited since 2013.

“On behalf of the entire Board of Management, I would like to thank both Jacques Perez and Neelanjan Banerjee for their excellent work and outstanding contributions to the company so far and wish them every success in their new roles” said Rainier van Roessel, Member of the Board of Management at LANXESS AG, commenting on the development.

LANXESS in India

LANXESS India was incorporated in India on February 20, 2004, and is represented through all its twelve business units, operating out of its registered office in Thane and sales offices in New Delhi and Chennai with around 1000 employees across its operations.

The company also has manufacturing facilities in India for five of its business units. The manufacturing sites are located in Nagda in Madhya Pradesh and Jhagadia in Gujarat. Production facilities for business units Liquid Purification Technologies (ion exchange resins), High Performance Materials (high tech plastics), Material Protection Products (biocides) and RheinChemie (polymer bound rubber chemicals and release agents) are operational in Jhagadia. The business unit Advanced Industrial Intermediates has production facilities both in Nagda and Jhagadia.

LANXESS has invested a sizeable amount in India over the years, in greenfield investments, acquisitions and in upgradation of assets, which validates the potential of the Indian chemical industry.

For more information on LANXESS India please go to www.lanxess.in

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

8 Ways Insomnia Affects Skin Health & How To Avoid It

By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…

1 day ago

Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and Treatment

Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…

1 day ago

Healthcare Startups to Watch Out for in 2025

New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…

2 days ago

DKMS’s First Global Impact Report of 2023 Serves as New Ray of Hope for Blood Cancer Patients Worldwide

National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…

2 days ago

Sterling Biotech to start world’s first precision fermentation-based dairy protein factory in Gujarat

Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…

3 days ago

Pioneers in Senior Care, Antara, Partners with Leading Diagnostics Player Dr. Lal PathLabs to Strengthen its Geriatric Care Services

New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…

3 days ago